REGISTERED NUMBER: 03798705 (England and Wales)

Unaudited Financial Statements for the Year Ended 30 April 2025

for

Pharma Pharma Ltd

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

N Siabi

Mrs T Siabi

REGISTERED OFFICE:

10 Nelmes Road

Hornchurch

Essex

RM11 3JA

REGISTERED NUMBER:

03798705 (England and Wales)

ACCOUNTANTS:

S C Devlin Accountancy Ltd

Chartered Certified Accountants

3 Marlborough Close

Benfleet

Essex

SS7 4JA

FIXED ASSETS

Intangible assets

4

4,751

4,751

Tangible assets

5

43,090

56,955

47,841

61,706

CURRENT ASSETS

Stocks

-

600

Debtors

6

288,630

263,007

Cash at bank

4,107

18,244

292,737

281,851

CREDITORS

Amounts falling due within one year

7

101,789

99,964

NET CURRENT ASSETS

190,948

181,887

TOTAL ASSETS LESS CURRENT LIABILITIES

238,789

243,593

CREDITORS

Amounts falling due after more than one year

8

159

2,759

NET ASSETS

238,630

240,834

CAPITAL AND RESERVES

Called up share capital

100

100

Retained earnings

238,530

240,734

SHAREHOLDERS' FUNDS

238,630

240,834

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 14 January 2026 and were signed on its behalf by:

N Siabi - Director

1.	STATUTORY INFORMATION

Pharma Pharma Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover represents amounts receivable for goods and services net of VAT and trade discounts.

Turnover is recognised upon transfer of the goods to the customer.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

25% on reducing balance and 20% on reducing balance

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

4.	INTANGIBLE FIXED ASSETS

Other

intangible

assets

£

COST

At 1 May 2024

and 30 April 2025

4,751

NET BOOK VALUE

At 30 April 2025

4,751

At 30 April 2024

4,751

Intangibles represents the costs of patents and licences and are not being depreciated.

5.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 May 2024

and 30 April 2025

97,498

DEPRECIATION

At 1 May 2024

40,543

Charge for year

13,865

At 30 April 2025

54,408

NET BOOK VALUE

At 30 April 2025

43,090

At 30 April 2024

56,955

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade debtors

24,471

32,498

Other debtors

264,159

230,509

288,630

263,007

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Bank loans and overdrafts

2,600

2,600

Trade creditors

10,427

3,186

Taxation and social security

4,778

4,491

Other creditors

83,984

89,687

101,789

99,964

8.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2025

2024

£

£

Bank loans

159

2,759

9.	RELATED PARTY DISCLOSURES

The company has extended its commercial loan provisions during the period to £235,130 (2024 - was £202,005) to a company with a common director and shareholder.

There are no fixed repayment terms and no interest is being charged.

10.	ULTIMATE CONTROLLING PARTY

The ultimate controlling party is N Siabi.